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Complications  following  gastrointestinal  surgery  may  require  re-intervention,  can  lead to prolonged
hospitalization,  and  signiﬁcantly  increase  health  costs.  Some  complications,  such  as  anastomotic  leak-
age, ﬁstula,  and  stricture  require  a multidisciplinary  approach.  Therapeutic  endoscopy  may  play  a pivotal
role in  these  conditions,  allowing  minimally  invasive  treatment.  Different  endoscopic  approaches,  includ-
ing  ﬁbrin  glue  injection,  endoclips,  self-expanding  stents,  and  endoscopic  vacuum-assisted  devices  havendoscopic clips
ndoscopic treatment
istula
ost-surgical complications
tenosis
tents
been  introduced  for  both  anastomotic  leakage  and  ﬁstula  treatment.  Similarly  endoscopic  treatments,
such  as  endoscopic  dilation,  incisional  therapy,  and  self-expanding  stents  have  been  used for anastomotic
strictures.  All these  techniques  can  be safely  performed  by skilled  endoscopists,  and  may  achieve  a high
technical  success  rate  in  both  the upper  and  lower  gastrointestinal  tract. Here  we will review  the  endo-
scopic  management  of post-surgical  complications;  these  techniques  should  be considered  as  ﬁrst-line
approach  in selected  patients,  allowing  to avoid  re-operation,  reduce  hospital  stay,  and  decrease  costs.
 Gast© 2013 Editrice
. Introduction
Despite continuous improvement in surgical procedures, com-
lications following gastrointestinal surgery may  represent a
readful event. Post-surgical complications lead to prolonged
ospitalization, often require one or more re-operations, and
igniﬁcantly increase health costs. Some complications, such as
nastomotic leakage, ﬁstula, stricture, and bleeding require a mul-
idisciplinary approach. Therapeutic endoscopy may  play a pivotal
ole in these conditions, allowing to resolve the complication with
inimally invasive treatment.
In this article we will review the available data from the liter-
ture to identify the most appropriate endoscopic approaches for
ifferent post-surgical complications in the gastrointestinal tract.
. Anastomotic leaks and ﬁstulasAnastomotic leakage is one of the most serious complications of
astrointestinal surgery. The reported incidence of gastrointestinal
∗ Corresponding author at: Gastroenterologia ed Endoscopia Digestiva, Nuovo
spedale S. Agostino, Viale Giardini 1355, 41100 Modena,
taly. Tel.: +39 059 3961843; fax: +39 059 3961216.
E-mail address: r.manta@libero.it (R. Manta).
590-8658/$36.00 ©  2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier
ttp://dx.doi.org/10.1016/j.dld.2013.03.008roenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
anastomotic leaks widely ranges from 5% to 30% for oesophageal
anastomoses [1–3], and from 5% to 15% for rectal resections [4–6].
Early anastomotic leaks occur in the ﬁrst post-operative week, and
generally require re-intervention. They are associated with a rel-
atively high rate of both morbidity and mortality, and a further
surgical procedure may  be required to restore intestinal continuity
[7]. Absolute indications for surgery are peritonitis or mediastini-
tis, persistent severe sepsis, and a large defect involving >50% of the
anastomotic circumference [8].
A substantial number of leaks and ﬁstulas occur later in the post-
operative period, often with subtle clinical manifestations. In this
setting, there is scarce consensus on the most appropriate treat-
ment option.
Selected patients can be successful treated by conservative
approaches, including parenteral nutrition, intravenous broad
spectrum antibiotics, and minimal surgical drainage [7]. In the
last decade, different endoscopic approaches have been proposed
for late gastrointestinal anastomotic leaks to obtain a less inva-
sive, non-surgical repair of lesions. These therapeutic procedures
include ﬁbrin glue injection, positioning of endoclips, suturing
devices, stent insertion and endoluminal vacuum devices. Before
treatment, endoscopic debridement is generally required, with
local removal of tissue remnants and elimination of pus within and
around the necrotic cavity, by using grasping tools and endolumi-
nal suction. In addition, the cavity should be rinsed with antiseptic
 Ltd. All rights reserved.
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uid and hydrogen peroxide [8], and complete drainage of ﬂuid
ollections in the mediastinum, pleural or peritoneal cavity is a
undamental prerequisite for a successful endoscopic procedure.
.1. Fibrin glue
Fibrin glue (Tissucol, Baxter, Germany) consists of two  frozen
omponents, glue and thrombin, applied by a double injection sys-
em. The mixture of both components results in a coagulum of ﬁbrin
ithin a short time. In our experience, ﬁbrin injection was able to
eal only very small leaks (<5 mm diameter) not connected to cav-
ties, and in the absence of abscesses. Although this is a relatively
asy procedure for both anastomotic leak and ﬁstula management,
everal reports demonstrated variable efﬁcacy. Moreover, there are
nly few large patient series in this setting [9]. In a retrospective
nalysis of 52 patients with ﬁstulas and anastomotic leakages in the
astrointestinal tract, endoscopic treatment was successful in 56%
f cases, though in cases with ﬁbrin glue application only, success
ate was 37%. Treatment success with further endoscopic proce-
ures was observed in 19% of cases, whilst a surgical intervention
as required in 23% of patients, with persistence of lesion in the
emaining 21% of cases. Eleven (21.1%) patients died during hospi-
alization, although only 2 deaths were potentially associated with
reatment [10].
Some favourable results have also been reported with a com-
ination of ﬁbrin glue and Vicryl plug [11]. In a recent study [12],
ostoperative upper gastrointestinal ﬁstulas or anastomotic leaks
ere successfully managed by endoscopic insertion of Vicryl mesh
ith ﬁbrin glue, and was associated with low morbidity. Of note,
his endoscopic treatment was successful in 13 (86.7%) out of 15
atients, achieving complete healing of the anastomotic leak or
stula after one to four treatment sessions.
.2. Endoclips
Standard clips are widely used in endoscopy, generally
or mechanical haemostasis following post-procedural bleeding.
oreover, their important role for endoscopic closure of small
erforations – i.e. immediately following polypectomy or muco-
ectomy – is widely recognized. However, data on the efﬁcacy of
ndoclips for the treatment of post-surgical leaks and ﬁstulas are
necdotal [13,14], the low closure strength limiting their use in
carred and hardened post-surgical tissues. To overcome such a
imitation, a new over-the-scope clip system, the OTSCR (Ovesco
ndoscopy, Tübingen, Germany), has been recently developed [15],
onsisting of a large Nitinol clip, loaded at the tip of the endo-
cope. Such a device allows to capture a large amount of tissue
nd to powerfully compress and close up the margins of a lesion
avouring its healing. It allows to close lesions up to 20 mm  in diam-
ter, whilst larger leaks are less amenable to treatment, although
ig. 1. Post-surgical anastomotic ﬁstula in a patient who underwent to video-laparosco
he-scope clip (OTSC®) positioning (B). Disease 45 (2013) 879– 885
application of two  adjacent OTSCs may  be attempted. Endoscopic
closure of post-surgical leaks and ﬁstulas with the OTSC applica-
tion is indicated for both early and late complications (Fig. 1). A
recent study [16] evaluated the efﬁcacy of the OTSC for treatment
of colorectal post-surgical leaks and ﬁstulas, enrolling patients with
an oriﬁce <15 mm in diameter without either luminal stenosis or
extraluminal abscesses. The overall success rate was  86% (87% in
early and 83% in late post-surgical leaks and ﬁstulas, respectively),
and surgery was required in only 1 case. These results conﬁrmed
our previous experience [17], where endoscopic OTSC positioning
was successful in 11 out of 12 (91.7%) patients with a post-surgical
ﬁstula with a diameter ranging from 6 to 25 mm.  Others studies
reported a lower efﬁcacy for treatment of chronic ﬁstulas [18]. In
a recent case series including 9 patients [19], the overall success
rate of OTSC application was 55%; the procedure was successful in
3 out of 5 patients with a leak, in 1 out of 3 patients with a ﬁstula,
and in the only patient with a perforation, whilst in the remaining
4 patients it was impossible to correctly deploy the OTSC due to
insufﬁcient grasping of the tissue caused by ﬁbrosis at the edges of
the lesion.
2.3. Self-expanding stents
Temporary placement of a fully (FSEMS) or partially (PSEMS)
covered self-expanding metal stent or a self-expanding plastic
stent (SEPS) is an effective treatment modality to seal anastomotic
leaks after gastro-oesophageal and bariatric surgery [20–23]. The
stent provides a physical barrier between the leak and the lumi-
nal contents, allowing healing of the wall lesions while providing
enteral nutrition (Fig. 2). The main drawbacks of stent placement
include either stent migration and tissue in- or overgrowth, par-
ticularly when the stents are positioned for a long period. Tissue
overgrowth, mostly occurring on the uncovered part of PSEMS, is
caused by a local ﬁbrotic reaction and/or the proliferation of gran-
ulation tissue that can be clinically manifest as early as 2 weeks
after stent placement, also causing difﬁculties in stent removal
[24]. On the other hand, the hyperplasic tissue growing into the
stent meshes may  reduce the risk of stent migration, providing
a better watertight barrier to saliva and ﬂuids, favouring ﬁstula
healing [25]. The clinical efﬁcacy and safety of temporary stent
placement in oesophageal anastomotic leaks and in leaks following
bariatric surgery has been evaluated in two recent reviews [24,26].
Overall, stent placement yielded clinical success in 85% out of 267
patients treated for oesophageal anastomotic leaks, with no differ-
ences among the different stents used [24]. The mean healing time
was 7 weeks (range: 6–8 weeks). Stent migration occurred in 25% of
patients, and it was observed most commonly with FSEMS as com-
pared to PSEMS, whilst tissue in- or over-growth was greater for the
latter, causing removal difﬁculties in some cases. Similar results
were reported in patients with leaks following bariatric surgery
pic left-colectomy due to local advanced colonic neoplasia (A). Closure with over-
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Eig. 2. Post-surgical anastomotic ﬁstula in a patient who  underwent to total gastrec
SEMS)  positioning across the ﬁstula tract (B). Healing of the ﬁstula at 2 months rad
nd managed with self-expandable stents [26]. Six to eight weeks
as been suggested as the optimal time for stent removal (Fig. 3).
ndeed, a shorter interval may  lead to incomplete closure, whilst
 longer interval may  cause either stent migration or excessive
ucosal overgrowth within the stent with subsequent dysphagia
r difﬁculty in stent extraction. In the latter case, a useful technique
o remove an embedded stent is to place a fully covered stent of
he same diameter inside the ﬁrst one. Such a procedure causes
ecrosis of the hyperplastic tissue and both stents can be more
asily removed after 7−14 days [27]. Although stent placement
as been proposed for leaks involving <70% of the circumference
28], complete closure has been achieved in a patient with com-
lete dehiscence [29]. Of note, prompt stent placement for the
losure of a leak or a perforation is of paramount importance, an
arly approach leading to a success rate of 100% as compared with
0% when stent insertion is carried out more than one month after
erforation [25].
ig. 3. Gastrographin® swallow shows a gastric staple-line leak with extravasation of 
Megastent®,  Taewoong Medical) is placed to treat both leak and stenosis (B). Endosco
ndoscopic follow-up two month after stent removal shows complete healing of the leakdue to local advanced gastric neoplasia (A). Closure with self-expanding metal stent
cal control and SEMS removal (C).
Minor complications associated with stent placement − par-
ticularly dysphagia − are reported in about 20% of patients, but
these may  be easily managed by either stent removal or balloon
dilation [24–26]. Major complications (bleeding, perforation and
tracheal compression) are rare and related to speciﬁc conditions
[24–26]. In some cases, an oesophageal stricture occurs as a long-
term complication following stent removal, requiring one or more
balloon dilations [25]. To date, the experience with rectal stents for
treatment of anastomotic leaks is limited [8].
2.4. Endoscopic vacuum-assisted devices
The endoscopic vacuum-assisted closure (VAC) system device
(Endo-SPONGE, B. Braun Medical Ltd) is a method ﬁrst introduced
in the 1990s. Basically, the system is based on negative pressure
applied to the wound with a tube inserted in a polyurethane foam,
resulting in arteriolar dilation, promotion of granulation tissue and
contrast medium and a substenosis in the middle part of the sleeve (A). A stent
pic control after stent removal: whitish granulation tissue ﬁlls the leak hole (C).
, with a wide ﬂat scar (D).
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ubsequent wound closure [30]. This method is generally applied
o large leaks in both thoracic and rectal anastomoses that may
e endoscopically explored, but few data are available in litera-
ure [31,32]. After endoscopic debridement of the wound cavity, a
ponge is trimmed to the speciﬁc size as estimated by the endo-
copist, ﬁxed at the distal end of the tube and introduced into the
ecrotic cavity, and then continuous suction is applied. The proce-
ure is repeated twice a week. Wedemeyer et al. [33] ﬁrst reported
he successful application of VAC therapy in two cases of intratho-
acic anastomotic leaks. After a median of 15 days and 5 endoscopic
essions, closure of the wound cavities was achieved in both cases.
n another study, complete healing of rectal anastomotic leaks was
btained in 28 (96.6%) out of 29 patients after vacuum therapy [32].
owever, bowel diversion cannot be avoided by vacuum-assisted
reatment of rectal leaks, because the sponge will be obstructed
y stool impaction. Other limitations include the need for repeated
ndoscopic interventions, continuous suction, and patient discom-
ort. On the other hand, the endoscopic VAC system allows a regular
isualization of the leak, debridement of the infected cavity, and
ontrol of septic foci [8,33]. An algorithm for post-anastomotic leak
nd ﬁstula management is provided in Fig. 4.
. Anastomotic strictures
The incidence of anastomotic stricture following gastrointesti-
al surgery is variable. Indeed, a stricture in the oesophago-gastric
nastomosis occurs in 5−46% of cases after oesophageal resection,
hile its incidence varies from 22% to 30% following colectomy
34–36]. Postoperative complications, such as anastomotic leak-
ge, ﬁstulas, or ischaemic injury contribute to anastomotic stricture
ormation [35]. Anastomotic strictures are generally short but tena-
ious, sometimes angulated, irregular or have a severely narrowed
iameter.astomotic leakage.
3.1. Endoscopic dilation
Commonly, endoscopic dilation therapy is the ﬁrst-line treat-
ment option for anastomotic strictures. The currently used dilators
can be either mechanical (Savary-Gilliard bougies) or balloon-type.
Mechanical dilators exert longitudinal and radial force on the stric-
ture, while balloon dilators only deliver radial force, however the
latter can be passed through-the-scope allowing direct endoscopic
control of the procedure. Endoscopic balloon dilation can be car-
ried out by two methods: (a) out-the-scope (OTS) or over-the-wire
(OTW) balloons of 35 mm diameter, and (b) through-the-scope
(TTS) balloons with a smaller diameter (18 mm). No clear advan-
tage has been demonstrated between balloon or bougie dilation
[37,38]. There is only one prospective trial comparing OTW versus
TTS balloon dilation in lower GI tract strictures, showing a simi-
lar efﬁcacy. However, fewer endoscopic sessions were needed to
achieve stricture resolution when OTW was used [39]. Generally,
1−3 dilations are needed in both upper and lower GI post-surgical
strictures with a success rate ranging from 59% to 100% [40–46].
However, 3 or more dilation sessions are needed in up to 40% of
patients to achieve an adequate result [42–46]. Furthermore, some
complex strictures may  require several sessions. Despite in these
cases re-operation should be considered, some patients unﬁt for
surgery may  beneﬁt from long-term continuous balloon dilations
[46].
The most frequent complications include haemorrhage, bac-
teraemia, and perforation, the last occurring in 0.1−0.4% of cases
[45,47]. To minimize the risk of perforation, the maximum dila-
tion diameter should not be increased by more than 3 mm per
session [42]. In order to prevent stricture recurrence, injection of
steroids into the stricture before dilation has been tested in various
studies aiming to inhibit the inﬂammatory response and to reduce
collagen formation [48,49]. A randomized study [50] found that
a combination of intra-lesional injection of 0.5 ml  triamcinolone
d Liver Disease 45 (2013) 879– 885 883
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40 mg/ml) plus dilation associated with gastric acid suppression
educed the number of dilation sessions and increased the average
ime between sessions. However, this study was limited to peptic
trictures.
.2. Incisional therapy
Undeniably, there is a subgroup of strictures that are refractory
r recurrent after dilation. A stricture is deﬁned refractory when
t is not possible to obtain a diameter of 14 mm after 5 dilation
essions carried out at 2-week intervals [51]. A recurrent stricture
s diagnosed when it is impossible to maintain an adequate lumi-
al diameter for 4 weeks after the target diameter of 14 mm has
een achieved [51]. Since it is very difﬁcult to treat refractory or
ecurrent strictures, an alternative approach is needed. The use of
ncisional therapy and temporary stent placement may  represent a
alid therapeutic approach in these selected cases. Incisional ther-
py consists in radial incisions on the stenotic ring, under direct
ndoscopic vision, with either sphincterotome or a needle knife
atheter. The number, length and depth of the cut is gauged by
he operator according to the length of the stricture and its cali-
re. The procedure is terminated when the endoscope can easily
e passed [52–54]. Some variants are reported in literature, such
s incisional therapy plus balloon dilation and incisional therapy
sing a polipectomy snare and additional argon plasma coagulation
55,56]. In a recent study [57], 24 patients with oesophageal ana-
tomotic strictures were treated with endoscopic incisional therapy
s ﬁrst-line treatment. Notably, as many as 87.5% of patients were
ysphagia-free at 24 months’ follow-up after a single endoscopic
ession. A randomized trial found no signiﬁcant difference in the
uccess rate between incisional therapy and dilation therapy with
avary-Gilliard balloons in 62 patients with a primary anastomotic
tricture after oesophagectomy [58]. Based on the available data,
ncisional therapy is a safe method in experienced hands, and par-
icularly effective in ‘ring type’ strictures (<10 mm).
.3. Self-expanding stents
In the past few years, temporary stent placement has been
ncreasingly used for refractory or recurrent anastomotic strictu-
es [59]. The purpose is to apply a prolonged radial force to the
tenosis, which reduces the risk of recurrent stricture formation.
tent types that have been used include PSEMS, FSEMS, and, more
ecently, biodegradable stents [60].
The same drawbacks of stent placement for anastomotic leakage
re also reported in this setting. Data on the use of SEMS in benign
esophageal anastomotic strictures are mostly available as case
eries and case reports. The most frequent complications include
igh migration rates, bleeding, ﬁstula, perforation, and stricture
ecurrence. The occurrence of tissue in- and over-growth caus-
ng recurrent dysphagia was observed in >15% of patients treated
ith PSEMS, while early migration (<4 weeks) was  found in 24% of
atients treated with plastic stents for benign oesophageal strictu-
es of variable causes [46,61]. For colonic stenting, there are few and
ontroversial data on the use of stents in benign colorectal diseases,
s the application of covered stents in benign colorectal strictures
s uncommon and there are only few case series with limited num-
er of patients or single case reports [63]. Studies have shown a
echnical success rate of 85−100% and a complication rate up to
0% [64]. Major complications reported in the literature include
erforation, secondary ﬁstula formation, and bleeding. The most
requent complication is stent migration, although conﬂicting data
ave been reported with migration rate in benign colorectal dis-
ase widely ranging from 5% and 24% [65,66]. Several techniques
ave been proposed to reduce the risk of stent migration. Recently,
t has been shown that anchoring the upper ﬂare of a fully coveredFig. 5. Flow-chart for anastomotic stricture.
SEMS with endoscopic clips signiﬁcantly reduces the risk of stent
migration [62]. Very proximal or distal localization of the stricture
or distal localization as well as angulated and narrowed strictures
are not suitable for stent application. Only a few data are available
on the use of stents in post-surgical lower GI tract strictures. In a
recent study, a success rate of 50% and 36% at 12-month and 37-
month follow-up respectively was  reported, with a migration rate
of 21%. A similar success rate (63%) was achieved in 8 patients with
lower anastomotic strictures at 20-month follow-up, with a single
case of stent migration [67].
Biodegradable stents represent a desirable and promising
technical innovation for both anastomotic leakage and stricture
management. The biodegradable stents in polydioxanon currently
available are able to dissolve and be absorbed within 3 months
after placement. Repici et al. reported a preliminary experience
on refractory benign oesophageal strictures showing a clinical suc-
cess in 45% of patients at 6-month follow-up, with stent migration
occurring in 10% of cases [68]. Larger studies with longer follow-
up are needed to evaluate their role in anastomotic leakage and
stricture management. An algorithm for post-anastomotic stricture
management is provided in Fig. 5.
4. Conclusions
All endoscopic techniques can be safely used with a high tech-
nical success rate for different post-surgical complications in both
upper and lower gastrointestinal tract. These procedures should be
performed by skilled endoscopists, generally in tertiary centres, due
to the learning curve. Indeed, these endoscopic approaches usu-
ally have a high complexity, and operator expertise reduces the
occurrence of complications, as well as of technical and clinical
failures. Although data on OTSC and vicryl plus tissucol combi-
nation are still scarce, the available data suggest that endoscopic
OTSC closure of a post-surgical leaks and ﬁstulas in gastrointesti-
nal tract is safe, and achieves a high success rate in both acute
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nd chronic cases, including recto-vaginal and percutaneous ﬁs-
ulas. Moreover, OTSCs seem to be more effective than traditional
ndoclip, vicryl and tissucol used alone. Treatment of gastroin-
estinal leaks with stents has considerably increased over the last
ecade, largely due to the availability of easily removable SEPS and
EMS, even though high stent migration rate still limits their efﬁ-
acy. Thus, more clinical experience and newer stent technologies
re needed to delineate the optimal conditions for SEMS place-
ent and to improve clinical outcomes. Endoscopic management
f post-surgical complications should be considered as the ﬁrst-
ine approach for selected patients. Indeed, such an approach may
void a re-operation, reduce the hospital stay, and decrease costs.
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